Vimarsana
Biggest News Aggregation in the World

Page 3 - Protein Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protein Sciences Today - Breaking & Trending Today

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript - Vimarsana News

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript

Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS - Vimarsana News

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2024. Third Quarter FY2024...

BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY - Vimarsana News

BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY

MINNEAPOLIS, April 26, 2024 /PRNewswire/ -- Bio-Techne Corporation and Novomol-Dx, a molecular diagnostics company, are pleased to announce the development of Bio-Marker Pathfinder , a first of...

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS - Vimarsana News

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 1, 2024, at...

Bio-Techne (NASDAQ:TECH) and Autolus Therapeutics (NASDAQ:AUTL) Head to Head Analysis - Vimarsana News

Bio-Techne (NASDAQ:TECH) and Autolus Therapeutics (NASDAQ:AUTL) Head to Head Analysis

Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) and Bio-Techne (NASDAQ:TECH – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Analyst Recommendations This is a breakdown of current ratings […]